June 16, 2022
SAN RAMON, Calif. — CooperVision’s MiSight 1 day contact lenses have expanded to include more prescriptions for myopic children.
Starting in June 2022, the lenses will include -0.50D to -7.00D (0.50D steps after -6.00D) in the U.S., covering nearly 100% of spherical prescriptions for age-appropriate children* (who were initially fit between ages 8-12) with myopia.1‡ The two new powers for this innovative, specially designed lens will allow even more children to benefit from myopia control.
“A greater range of MiSight 1 day powers is excellent news for my practice and patients,” said Charles Morgan, MD, of Advocare Pediatric Eye Physicians in Morristown, NJ. “We have age-appropriate* patients with higher levels of myopia who will now be able to access MiSight’s proven myopia control benefits.”2†
The expanded range will be included in CooperVision’s OptiExpert Contact Lens Calculator, an app-based tool that helps eye care professionals by calculating back vertex distance and displaying the closest power-matched MiSight 1 day prescription for a patient.
“Every diopter matters, particularly for children whose myopia progression may have already placed them at a higher risk for conditions such as myopic maculopathy and glaucoma,”3 said Elizabeth Lumb, BSc (Hons) MCOptom, FBCLA, Director of Global Professional Affairs, Myopia Management, CooperVision. “While early treatment is best, it’s never too late to start.”
*Indications for Use: MiSight® 1 day (omafilcon A) soft (hydrophilic) contact lenses for daily wear are indicated for the correction of myopic ametropia and for slowing the progression of myopia in children with non-diseased eyes, who at the initiation of treatment are 8-12 years of age and have a refraction of -0.75 to -4.00 diopters(spherical equivalent) with ≤ 0.75 diopters of astigmatism. The lens is to be discarded after each removal.
‡Includes prescriptions up to 0.75DC
†Compared to a single vision 1 day lens over a 3-year period.
1 CVI Data on file, 2022. SERE coverage of childhood myopia prescriptions with MiSight 1 day for 104,810 eyes in Asia (China, Korea) and 116,336 eyes in Europe and USA aged 8-18 years.
2 Chamberlain P, et al. A 3-year Randomized Clinical Trial of MiSight Lenses for Myopia Control. Optom Vis Sci. 2019; 96(8)556-567.
3 Bullimore et al. Myopia Control: Why Each Diopter Matters. Optom Vis Sci 2019;96:463–465.